Hypertensive patients who present left ventricular hypertrophy (LVH) are at considerable risk of developing cardiovascular complications. Echocardiography, being the best method for assessing of LVH, is too expensive for routine daily practice particularly in primary health care. Therefore, electrocardiogram (ECG) still remains the most feasible method to assess LVH in these settings. Objectives: The aim of this study was to determine the prevalence of ECG-LVH in Finnish hypertensive primary health care patients and evaluate the quality of their blood pressure control. Methods: A total of 255 general practitioners in 26 primary health care centres identified all of their hypertensive patients visiting during a 1-week period. A health examination was carried out on these patients by health
Introduction
There has been a remarkable reduction in the incidence of coronary heart disease (CHD) in Finland since the 1970s. 1 Nevertheless, the prevalence of CHD still remains one of the highest in the world. 2 Hypertension is one of the major risk factors for CHD. 3, 4 Furthermore, long standing hypertension is the main factor leading to left ventricular hypertrophy (LVH). 5 On the other hand, LVH can be considered as an indicator of the severity of hypertension. 5, 6 Patients who present LVH are at considerable risk of developing CHD, congestive heart failure, stroke or sudden death. [5] [6] [7] [8] [9] [10] In clinical practice, echocardiography is the best method for assessing of LVH. 11 In primary health care, however, echocardiography is too expensive and out of reach regarding human resources for rou-tine daily clinical practice. Thus, ECG remains the most feasible method for clinicians to assess LVH in primary health care settings. The aim of this study was to determine the exact prevalence of ECG-LVH in Finnish hypertensive primary health care patients and evaluate the quality of blood pressure control in these patients.
Subjects and methods
In October 1996, 255 general practitioners in 26 health centres, randomly selected from the total of 250 health centres in Finland, identified all of their hypertensive patients who visited doctor during a 1-week period. During the following 3 months the patients were subsequently called to receive a health examination, which was performed by trained health nurses. Blood pressure was measured twice in each patient after a 10-15 min rest in a sitting position. In statistical analyses, the mean value of these two readings was used. For anthropometric measurements, subjects were examined while wearing light clothes. Height was measured to the nearest cm, weight to the nearest 0.1 kg. Body mass index
Journal of Human Hypertension (BMI) was calculated as a function of weight (kg) divided by height squared (m 2 ). A 12-lead ECG was taken and careful attention was paid to the proper positioning of electrodes.
Each ECG was then carefully measured twice and coded according to the Minnesota code. 12 The coding was done by one research fellow (JL) after careful training, and under the supervision of an experienced cardiologist (HM). The reader's skill was assessed in the following way; after coding all the ECGs, the first 100 and another randomised 100 ECGs were recoded by the same coder (JL). The retest reliability was 0.98. Next, an additional 40 randomised ECGs were coded by JL and by the same cardiologist to assess the inter-rater reliability. The concordance was 0.80. The difference was primarily due to the interpretation of the Minnesota code 5-3 (T-wave flat or zero). If the 5-3 code was excluded the achieved concordance was 0.94.
LVH was measured using the Sokolow-Lyon method (SV 1 + SV 5/ SV 6 Ͼ 3.8 mV) and by the Cornell QRS voltage-duration product, which was for men (RaVL + SV3) * QRS duration Ͼ 244 mV*ms and for women (RaVL + SV3 + 6 mm) * QRS duration Ͼ 244 mV*ms. [13] [14] [15] Statistical analyses were performed by using SPSS statistical software for Windows, version 7.5. The Chi-square test and independent sample t-test were used as statistical methods.
Results
The 255 general practitioners identified a total of 2219 hypertensive patients, of which 1782 (80.3%) (705 males and 1077 females) participated in the health examination. A 12-electrode ECG was obtained from all of the patients. Thirty-six of these ECG's were excluded because of incomplete data. Thus, the final study material consisted of 1746 hypertensive patients. The clinical characteristics of the subjects are shown in Table 1 . The mean age of all patients was 63.6 years, where LVH patients were 5 years older than non-LVH patients. The mean systolic blood pressure of patients with LVH was significantly higher than that of non-LVH patients' (P Ͻ 0.01), but the mean diastolic blood pressure did not differ significantly between these groups. The difference in mean BMI between these two groups was also not statistically significant.
The prevalence of LVH was as follows: 9.8% for males according to the Sokolow-Lyon criterion, 5.7% for females and 7.5% for all patients. Using the sex-specific Cornell product criterion, the corresponding figures were 14.9% for males, 18,8% for females and 17,3% for all patients.
The majority of the patients with LVH (62%) reported having had hypertension for more than 10 years, 13% for 5-10 years and 24% for less than 5 years. The corresponding figures for non-LVH patients were 48%, 22%, and 31% respectively. Focusing on the age group under 60 years old, 43% of the LVH patients had had hypertension for more than 10 years whereas the corresponding figure for non-LVH patients was 30% (P Ͻ 0.05). Females seemed to have had hypertension longer than males; 13% had been hypertensive for 5-10 years and 65% for more than 10 years. The corresponding figures for men were 15% and 58%, respectively.
One LVH patient out of six was found to have good control of blood pressure (BP Ͻ140/90 mm Hg) as compared with one non-LVH patient out of four. When applying the criterion BP Ͻ160/90 mm Hg the difference between the groups, although not remarkable, was still statistically significant (Table 1) .
Drug treatment between LVH and non-LVH patient groups did not differ from each other remarkably. The main therapeutic drug groups were as follows: diuretics 39% for LVH patients and 38% for non-LVH patients, beta-blockers 50% and 45%, calcium blocking agents 33% and 30%, and ACE inhibitors 34% and 33%, respectively. Eleven per-cent of LVH patients and 12% of non-LVH patients did not have any drug treatment for their high blood pressure.
Discussion
Our study revealed the high prevalence of ECG-LVH in Finnish hypertensive patients treated in primary health care; 9.8% for males and 5.7% for females according to the Sokolow-Lyon criterion, and 14.9% for males and 18,8% for females using the sex-specific Cornell voltage duration criterion. In earlier studies, the prevalence of ECG-LVH in hypertensive patients has varied from 3.9% to 14.5%, depending on the criteria employed (Framingham vs SokolowLyon criterion) and the selected patient populations. [16] [17] [18] [19] In primary health care hypertensive patients, however, up to 21% ECG-LVH prevalence rate has been reported. 20 There may be several reasons for the high prevalence of ECG-LVH in the present study, such as methodological factors, particular characteristics of the patient population and effectiveness in the control of their hypertension. As far as methodological issues are concerned, the research fellow was carefully trained for Minnesota coding and reliability was strictly controlled by an experienced cardiologist. The inter-rater reliability was good, particularly after taking into account the Minnesota code 5-3 (0.94). Furthermore, the re-test reliability obtained a level of 0.98. The great majority of ECG prints were of good quality, and only 2% (36 ECGs) were incomplete, with respect to LVH issues. In the general practices, the ECG's were taken by trained nurses who ensured the proper placing of electrodes, and that the skin was carefully shaven before placing the electrodes.
The main methodological weakness, the low sensitivity of ECG-LVH, however, still exists also in our study. Based on echocardiographical measurements, the sensitivity of ECG-LVH has ranged from 12-29% for the Sokolow-Lyon criterion and 2-42% for the sex-specific Cornell product. 11, [16] [17] [18] Echocardiography, being far more sensitive than ECG, has been reported to detect LVH in 25-35% of all hypertensive patients. 16, 17, 19, 21 On the other hand, ECG-LVH exhibits high specificity, being 85-100%, depending on the criteria employed. 11, 18, [22] [23] [24] At the population level, the prevalence of LVH is dependent on the prevalence of hypertension and the mean level of blood pressure. 25 In Finland, the prevalence of hypertension is high, and typically ranges from 27-31% for men aged 25-64, and from 16-21% for women of the same age. Furthermore, the average blood pressure level in both male and female populations is still high by international standards. 26 In our recent study on the quality of care of hypertensive primary health care patients in Finland, only 13% of the men and 10% of the women had their blood pressure under good control; ie, BP Ͻ140/90
Journal of Human Hypertension mm Hg. The corresponding figures were 27% and 28% for BP Ͻ160/90 mm Hg. 27 Therefore, a high prevalence rates for LVH could be expected in Finnish hypertensive patients.
The mean age of the patients was 64 years, where LVH patients were 5 years older than non-LVH patients. Although the hypertensive patients in our study were slightly older than those in corresponding clinical studies, age does not seem to explain the difference in prevalence rates of LVH. [16] [17] [18] 28 It seems more likely that the duration of hypertension and blood pressure levels, in our study, play more important roles in explaining the prevalence of LVH. Most of our LVH patients (62%) had had hypertension for more than 10 years whereas the figure for non-LVH patients was 48%. This difference between LVH and non-LVH patients still remained when taking the age into consideration. The percentage of the LVH patients under 60 years old with history of hypertension for more than 10 years was 43% as compared to 30% of the non-LVH patients in the same age group. In this respect, our results differ slightly from the evidence of ECG-LVH in Dutch primary health care hypertensives. 20 The mean systolic pressure for all patients was 153 mm Hg and the mean diastolic pressure was 89 mm Hg. The systolic pressure for LVH patients was even higher, the mean value being as high as 159 mm Hg. Only 17% of LVH patients were in good control when applying the criterion BP Ͻ140/90 mm Hg as compared to 25% of non-LVH patients. Furthermore, only 40% of LVH patients reached the level BP Ͻ160/90 mm Hg.
In conclusion, our study shows that careful ECG can reveal LVH in every sixth of fifth hypertensive patient treated in primary health care centres. As a cost-effective and reliable method it is still a useful tool in primary health care settings. The LVH patients, in particular, should be identified and carefully treated because of the high risk of cardiovascular sequelae.
